Influenza A Virus Subpopulations and Their Implication in Pathogenesis and Vaccine Development
- PMID: 31479617
- DOI: 10.1146/annurev-animal-021419-083756
Influenza A Virus Subpopulations and Their Implication in Pathogenesis and Vaccine Development
Abstract
The concept of influenza A virus (IAV) subpopulations emerged approximately 75 years ago, when Preben von Magnus described "incomplete" virus particles that interfere with the replication of infectious virus. It is now widely accepted that infectious particles constitute only a minor portion of biologically active IAV subpopulations. The IAV quasispecies is an extremely diverse swarm of biologically and genetically heterogeneous particle subpopulations that collectively influence the evolutionary fitness of the virus. This review summarizes the current knowledge of IAV subpopulations, focusing on their biologic and genomic diversity. It also discusses the potential roles IAV subpopulations play in virus pathogenesis and live attenuated influenza vaccine development.
Keywords: biological activity; cell-killing particles; defective-interfering particles; influenza A virus subpopulations; interferon-inducing particles; pathogenesis and vaccine development.
Similar articles
-
Bordetella bronchiseptica Colonization Limits Efficacy, but Not Immunogenicity, of Live-Attenuated Influenza Virus Vaccine and Enhances Pathogenesis After Influenza Challenge.Front Immunol. 2018 Oct 4;9:2255. doi: 10.3389/fimmu.2018.02255. eCollection 2018. Front Immunol. 2018. PMID: 30337924 Free PMC article.
-
Live Attenuated Influenza Vaccine contains Substantial and Unexpected Amounts of Defective Viral Genomic RNA.Viruses. 2017 Sep 21;9(10):269. doi: 10.3390/v9100269. Viruses. 2017. PMID: 28934167 Free PMC article.
-
Development of an Alternative Modified Live Influenza B Virus Vaccine.J Virol. 2017 May 26;91(12):e00056-17. doi: 10.1128/JVI.00056-17. Print 2017 Jun 15. J Virol. 2017. PMID: 28381580 Free PMC article.
-
AGL2017-82570-RReverse genetics approaches for the development of new vaccines against influenza A virus infections.Curr Opin Virol. 2020 Oct;44:26-34. doi: 10.1016/j.coviro.2020.06.001. Epub 2020 Jun 27. Curr Opin Virol. 2020. PMID: 32599532 Free PMC article. Review.
-
Pathogenesis and vaccination of influenza A virus in swine.Curr Top Microbiol Immunol. 2014;385:307-26. doi: 10.1007/82_2014_391. Curr Top Microbiol Immunol. 2014. PMID: 25033752 Review.
Cited by
-
Expanding Mouse-Adapted Yamagata-like Influenza B Viruses in Eggs Enhances In Vivo Lethality in BALB/c Mice.Viruses. 2022 Jun 14;14(6):1299. doi: 10.3390/v14061299. Viruses. 2022. PMID: 35746770 Free PMC article.
-
Influenza a Neuraminidase-Based Bivalent mRNA Vaccine Induces Th1-Type Immune Response and Provides Protective Effects in Mice.Vaccines (Basel). 2024 Mar 13;12(3):300. doi: 10.3390/vaccines12030300. Vaccines (Basel). 2024. PMID: 38543934 Free PMC article.
-
Defective Interfering Particles of Influenza Virus and Their Characteristics, Impacts, and Use in Vaccines and Antiviral Strategies: A Systematic Review.Viruses. 2022 Dec 12;14(12):2773. doi: 10.3390/v14122773. Viruses. 2022. PMID: 36560777 Free PMC article.
-
Diversity and Complexity of Internally Deleted Viral Genomes in Influenza A Virus Subpopulations with Enhanced Interferon-Inducing Phenotypes.Viruses. 2023 Oct 17;15(10):2107. doi: 10.3390/v15102107. Viruses. 2023. PMID: 37896883 Free PMC article.
-
Viral Subpopulation Screening Guides in Designing a High Interferon-Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.J Virol. 2020 Dec 22;95(2):e01722-20. doi: 10.1128/JVI.01722-20. Print 2020 Dec 22. J Virol. 2020. PMID: 33115873 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources